October 6, 2021

NSW Health & Medical Research | Melanoma breakthroughs

Through world-leading genetic work, NSW researchers are discovering why about 50% of melanomas don’t respond to immunotherapy. Over the past decade, immunotherapy drugs have become the standard treatment for metastatic (or Stage IV) melanomas. These drugs help someone’s immune system recognise and fight a tumour by preventing tumour cells from obstructing the body’s immune checkpoints....
Read More

About Us

GCG Global Healthcare are specialists in healthcare excellence. Driven by a desire to improve healthcare and clinical solutions for everyone – patients, medical professionals and facilities. We aim to foster a culture of excellence through collaboration with industry experts and thought leaders to deliver better outcomes.